Delivery Order SPE2DR25D1202-SPE2DR26F72FR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This order, valued at $5,621.13, represents a firm fixed-price delivery order with an ultimate completion date of November 4, 2025. The contract was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30 count) with a contract ceiling value of $5,618.72. The award was issued on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with a ceiling value of $1,278.55. This firm fixed-price delivery order, which is not a set-aside contract, represents a competitive award to one of the federal government's largest pharmaceutical distributors. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,169.62 and an ultimate completion date of September 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for Terbinafine HCL 250 mg tablets in a quantity of 90 units, with a ceiling value of $2,974.16. This firm fixed-price delivery order, which is scheduled for completion by November 10, 2025, represents a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, valued at $36,969.40. This firm fixed-price contract, with an ultimate completion date of November 4, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,838.56 for Terbinafine HCL 250 mg tablets (90-count units) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $2,964.57. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract is expected to be completed by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,994.33 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 22, 2025, with a completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under the Defense Logistics Agency's...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72FRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on November 17, 2025, with a ceiling value of $1,110.08 and a firm fixed price structure. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. The company's SPE2DX prime IDC functions as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support Defense Health Agency operations and other government healthcare customers worldwide. This delivery order represents one of numerous task orders placed against this expansive contract vehicle to fulfill ongoing federal pharmaceutical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/17/25 |